Sakar Healthcare Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 43.15 | 41.61 | 43.83 |
| Operating Expense | 31.28 | 30.45 | 32.09 |
| Net Profit | 4.80 | 2.41 | 3.12 |
| Net Profit Margin | 11.12 | 5.79 | 7.12 |
| Earning Per Share | 2.17 | 1.10 | 1.46 |
| EBIDTA | 11.56 | 8.87 | 10.07 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 43.15 |
| Operating Expense | 31.28 |
| Net Profit | 4.80 |
| Net Profit Margin | 11.12 |
| Earning Per Share | 2.17 |
| EBIDTA | 11.56 |
| Effective Tax Rate | TBA |
Invest in Sakar Healthcare Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 153.35 | 133.36 | 128.23 |
| Operating Expenses Annual | 114.99 | 100.22 | 98.83 |
| Operating Profit Annual | 41.54 | 37.81 | 31.57 |
| Interest Annual | 7.59 | 5.95 | 2.90 |
| Depreciation | 18.05 | 14.99 | 9.67 |
| Net Profit Annual | 11.67 | 12.76 | 15.24 |
| Tax Annual | 4.23 | 4.12 | 3.77 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 153.35 |
| Operating Expenses Annual | 114.99 |
| Operating Profit Annual | 41.54 |
| Interest Annual | 7.59 |
| Depreciation | 18.05 |
| Net Profit Annual | 11.67 |
| Tax Annual | 4.23 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.09 | 0.03 | 0.08 |
| Cash Flow from Operations | 24.47 | 33.34 | 35.79 |
| Cash Flow from Investing | -51.54 | -74.38 | -90.40 |
| Cash Flow from Financing | 27.44 | 41.10 | 54.56 |
| Cash Flow at the End | 0.46 | 0.09 | 0.03 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.09 |
| Cash Flow from Operations | 24.47 |
| Cash Flow from Investing | -51.54 |
| Cash Flow from Financing | 27.44 |
| Cash Flow at the End | 0.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 27.09 | 28.35 | 24.63 |
| PBIT Margin (%) | 15.32 | 17.11 | 17.09 |
| PBT Margin (%) | 13.31 | 14.23 | 11.19 |
| Net PROFIT Margin (%) | 7.61 | 9.57 | 11.88 |
| Return On Networth / Equity (%) | 5.36 | 8.48 | 13.49 |
| Return On Networth /Employed (%) | 7.36 | 8.85 | 12.05 |
| Return On Assets (%) | 3.65 | 4.98 | 8.44 |
| Total Debt / Equity (X) | 0.46 | 0.70 | 0.60 |
| Asset Turnover Ratio (%) | 0.48 | 0.52 | 0.71 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 27.09 |
| PBIT Margin (%) | 15.32 |
| PBT Margin (%) | 13.31 |
| Net PROFIT Margin (%) | 7.61 |
| Return On Networth / Equity (%) | 5.36 |
| Return On Networth /Employed (%) | 7.36 |
| Return On Assets (%) | 3.65 |
| Total Debt / Equity (X) | 0.46 |
| Asset Turnover Ratio (%) | 0.48 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 314.29 | 266.64 | 204.65 |
| Total Current Assets Annual | 71.69 | 55.99 | 50.10 |
| Non Current Assets Annual | 317.06 | 280.43 | 217.75 |
| Total Shareholders Funds Annual | 262.42 | 173.43 | 127.54 |
| Total Assets Annual | 388.74 | 336.42 | 267.85 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 314.29 |
| Total Current Assets Annual | 71.69 |
| Non Current Assets Annual | 317.06 |
| Total Shareholders Funds Annual | 262.42 |
| Total Assets Annual | 388.74 |
EPS (INR)
Expected
2.21
Reported
2.17
Surprise
-1.81%
Jun 2024
EPS beaten by -1.81%
Mar 2024
EPS beaten by -0.90%
Dec 2023
EPS beaten by 2.10%
